Status:
WITHDRAWN
Involvement of Endogenous Digitalis-like Compounds in Breast Cancer
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Breast Neoplasms
Fibrocystic Disease of Breast
Eligibility:
FEMALE
18-65 years
Brief Summary
The endogenous digitalis-like compounds (DLC)are steroid hormones synthesized and released from the adrenal gland.They are integrated in the feed-back system of the Hypothalami-Pituitary-Adrenal gland...
Detailed Description
To pursue this question about endogenous DLC metabolism in cancer patients we intend to start with the measurement of DLC plasma levels in breast cancer patients at the time of first diagnosis and com...
Eligibility Criteria
Inclusion
- first visit to a Breast Disease Ambulance for consultation
- no pregnancy
Exclusion
- no severe heart disease (EF \> 40%)
- no therapy with digitalis
- no acute/chronic inflammatory disease (e.g. RA, M. Crohn)
- no dysfunction of the Hypothalamo-Pituitary-Adrenal system
- no severe mental disorder
Key Trial Info
Start Date :
May 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2008
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00310882
Start Date
May 1 2006
End Date
May 1 2008
Last Update
April 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Hebrew University Medical Centers
Jerusalem, Israel